StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD)

Stock analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 target price on shares of Aethlon Medical in a research report on Friday.

Aethlon Medical Price Performance

NASDAQ AEMD opened at $0.40 on Friday. The business has a fifty day moving average price of $0.40 and a 200 day moving average price of $0.48. Aethlon Medical has a one year low of $0.24 and a one year high of $2.35.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.